Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2014

Jan 17, 2014

30198_dirs_2014-01-17_aeeaf63c-c986-42b4-acc2-8ee126837cc5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-01-15

Reporting Person: GREGG TERRANCE H (Director, CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-01-15 Common Stock M 25000.0 $6.85 Acquired 237813 Direct
2014-01-15 Common Stock S 25000.0 $36.86 Disposed 212813 Direct
2014-01-15 Common Stock S 10000.0 $36.8581 Disposed 722889 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-01-15 Non-Qualified Stock Option (right to buy) $6.85 M 25000.0 Disposed 2017-06-19 Common Stock (25000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 11461 Indirect

Footnotes

F1: On December 09, 2013, Mr. Gregg adopted a 10b5-1 Plan. Under this 10b5-1 Plan, Mr. Gregg will sell a limited number of shares to cover the tax liability that accrues upon monthly vesting of restricted stock units previously granted to Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: This transaction was executed in multiple trades at prices ranging from $36.56 to $37.22. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F3: Included in this number are 132,032 unvested restricted stock units granted on March 11, 2013, 5,078 of which shall vest each month through March 11, 2016.

F4: This transaction was executed in multiple trades at prices ranging from $36.56 to $37.15. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F5: Included in this number are 71,094 unvested restricted stock units granted on March 8, 2012, 5,078 of which shall vest each month through March 8, 2015 and 10,157 unvested restricted stock units granted on March 8, 2011, 5,078 of which shall vest each month through March 8, 2014.

F6: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.